Literature DB >> 23188160

[Echocardiography in diabetic cardiomyopathy].

M Niemann1, S Herrmann, G Ertl, F Weidemann.   

Abstract

The term diabetic cardiomyopathy was initially introduced in the 1980s when evidence was found that diabetes leads to a distinct cardiomyopathy, independent of coronary artery disease or hypertension. The detection of diabetic cardiomyopathy using echocardiography is challenging because no pathognomonic signs exist; however, it is the merit especially of the newer echocardiographic techniques, such as deformation imaging, that it is now possible to describe the morphology and function of diabetic hearts. Unfortunately, no long-term echocardiography studies are available describing disease progression in detail. Therefore, staging and differential diagnosis of diabetic cardiomyopathy remains challenging. This review tries to fill this gap by presenting a possible echocardiographic staging algorithm. Early stages of diabetic cardiomyopathy are marked by a deterioration of longitudinal systolic function and a compensative elevated radial function. Diastolic dysfunction is another early sign. When the disease progresses the functional deterioration is accompanied by morphological changes, such as left ventricular concentric hypertrophy and fibrosis. End stage disease is characterized by reduced ejection fraction and ventricular dilatation. Very late stage can mimic dilative cardiomyopathy.

Entities:  

Mesh:

Year:  2012        PMID: 23188160     DOI: 10.1007/s00059-012-3726-6

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  41 in total

Review 1.  Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths.

Authors:  Allan D Struthers; Andrew D Morris
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

Review 2.  Diabetic cardiomyopathy.

Authors:  Eser Acar; Dilek Ural; Ulaş Bildirici; Tayfun Sahin; Irem Yılmaz
Journal:  Anadolu Kardiyol Derg       Date:  2011-12-03

3.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.

Authors:  P Gaede; P Vedel; H H Parving; O Pedersen
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

4.  In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans.

Authors:  E Picano; G Pelosi; M Marzilli; F Lattanzi; A Benassi; L Landini; A L'Abbate
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

5.  Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging.

Authors:  P Di Bonito; N Moio; L Cavuto; G Covino; E Murena; C Scilla; S Turco; B Capaldo; G Sibilio
Journal:  Diabet Med       Date:  2005-12       Impact factor: 4.359

6.  Progression of subclinical myocardial dysfunction in type 2 diabetes after 5 years despite improved glycemic control.

Authors:  Vlad Damian Vintila; Aled Roberts; Dragos Vinereanu; Alan Gordon Fraser
Journal:  Echocardiography       Date:  2012-06-05       Impact factor: 1.724

Review 7.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

8.  Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus.

Authors:  S Nunoda; A Genda; N Sugihara; A Nakayama; S Mizuno; R Takeda
Journal:  Heart Vessels       Date:  1985-02       Impact factor: 2.037

Review 9.  Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.

Authors:  Ashish Aneja; W H Wilson Tang; Sameer Bansilal; Mario J Garcia; Michael E Farkouh
Journal:  Am J Med       Date:  2008-09       Impact factor: 4.965

10.  Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine.

Authors:  Zhi You Fang; Ofelia Najos-Valencia; Rodel Leano; Thomas H Marwick
Journal:  J Am Coll Cardiol       Date:  2003-08-06       Impact factor: 24.094

View more
  2 in total

Review 1.  Updating experimental models of diabetic cardiomyopathy.

Authors:  J Fuentes-Antrás; B Picatoste; A Gómez-Hernández; J Egido; J Tuñón; Ó Lorenzo
Journal:  J Diabetes Res       Date:  2015-04-20       Impact factor: 4.011

2.  Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.

Authors:  Gareth S D Purvis; Fausto Chiazza; Jianmin Chen; Rodrigo Azevedo-Loiola; Lukas Martin; Dennis H M Kusters; Chris Reutelingsperger; Nikolaos Fountoulakis; Luigi Gnudi; Muhammed M Yaqoob; Massimo Collino; Christoph Thiemermann; Egle Solito
Journal:  Diabetologia       Date:  2017-10-30       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.